The following details are available for trading and market data about the stock of Cybin as of writing:
Trading Details of Cybin (CYBN)
Current Share Price:
$0.53
Previous Year's Closing Price:
$0.53
Percentage Price Change (YTD):
0%
Market Cap:
$217.75 million
52-week Price Range:
$0.3 - $0.98
Dividend Per Share:
$0
EPS (TTM):
-0.3
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
0
Currency:
Canadian dollars (CAD)
All prices are mentioned in Canadian dollars (CAD) currency, unless the given financial security trades in any other currency.
Company Profile and Business Description for Cybin
Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa-b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.
Canada Stock Screener:
Peer / Competitor Companies of Biotechnology Sector
Along with Cybin Inc., the following other peer (competitor) companies also exist within the same Biotechnology - Healthcare sector whose company profile and dividend history is as follows:
▶ Acasti Pharma (ACST): Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment....See Detailed Company Profile
▶ Advanced Proteome (APC): Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the....See Detailed Company Profile
▶ Aeterna Zentaris (AEZS): Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead....See Detailed Company Profile
▶ Algernon Pharmaceuticals (AGN): Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic....See Detailed Company Profile
▶ Alpha Cognition (ACOG): Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimers disease and amyotrophic lateral....See Detailed Company Profile
▶ Antibe Therapeutics (ATE): Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent protected pharmaceuticals in Canada,....See Detailed Company Profile
▶ Appili Therapeutics (APLI): Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious....See Detailed Company Profile
▶ Aptose Biosciences (APS): Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in....See Detailed Company Profile
▶ Arch Biopartners (ARCH): Arch Biopartners Inc., a biotechnology company, develops technologies for improving the health of patients. The company develops AB569, a drug candida....See Detailed Company Profile
▶ Asep Medical Holdings Inc (ASEP): Asep Medical Holdings Inc., through its subsidiary, ASEP Medical Inc. focuses on developing an early diagnostic tool for Sepsis and peptide therapeutic....See Detailed Company Profile
▶ Aurinia Pharmaceuticals (AUP): Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutic....See Detailed Company Profile
▶ Awakn Life Sciences (AWKN): Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, and delivering of psychedelic therapeutics to treat addiction....See Detailed Company Profile
▶ BELLUS Health (BLU): BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other....See Detailed Company Profile
▶ BetterLife Pharma (BETR): BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental....See Detailed Company Profile
▶ biOasis Technologies (BTI): Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and....See Detailed Company Profile
▶ Biocure Technology (CURE): Biocure Technology Inc. develops and commercializes biopharmaceutical technologies for uses in recombinant and ranibizumab. The company is developing....See Detailed Company Profile
▶ Biomind Labs (BMND): Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various....See Detailed Company Profile
▶ BioVaxys Technology (BIOV): BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent....See Detailed Company Profile
▶ Braxia Scientific (BRAX): Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related....See Detailed Company Profile
▶ Briacell Therapeutics (BCT): BriaCell Therapeutics Corp., an immuno-oncology focused biotechnology company, engages in developing approaches for the management of cancer. The....See Detailed Company Profile
Stock Lists of Other Canadian Healthcare Subsectors: